ImmunoGen, Inc. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ImmunoGen, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2023.
  • ImmunoGen, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was $26M.
  • ImmunoGen, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$80.2M, a 59.1% increase year-over-year.
  • ImmunoGen, Inc. annual Operating Income (Loss) for 2022 was -$221M, a 76.6% decline from 2021.
  • ImmunoGen, Inc. annual Operating Income (Loss) for 2021 was -$125M, a 459% decline from 2020.
  • ImmunoGen, Inc. annual Operating Income (Loss) for 2020 was -$22.4M, a 75.7% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$80.2M $26M +$103M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$184M -$4.19M +$56.9M +93.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-31
Q1 2023 -$240M -$42.4M -$19.5M -85.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-04-28
Q4 2022 -$221M -$59.6M -$25M -72.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-01
Q3 2022 -$196M -$77.4M -$43.2M -126% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$153M -$61.1M -$33.7M -123% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-31
Q1 2022 -$119M -$22.9M +$6.06M +21% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 -$125M -$34.6M -$71.1M -195% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$54M -$34.2M -$17.5M -105% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$36.5M -$27.4M -$9.01M -49.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-01
Q1 2021 -$27.5M -$28.9M -$5.11M -21.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$22.4M $36.5M +$28M +330% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$50.4M -$16.7M +$1.24M +6.88% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 -$51.6M -$18.4M +$22.7M +55.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 -$74.3M -$23.8M +$17.8M +42.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$92.2M $8.49M +$48.9M Oct 1, 2019 Dec 31, 2019 10-K 2020-03-11
Q3 2019 -$141M -$18M +$27.6M +60.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$169M -$41.1M -$2.31M -5.95% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$166M -$41.6M -$4.9M -13.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 -$161M -$40.4M -$30.6M -311% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-11
Q3 2018 -$131M -$45.5M -$14.4M -46.3% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-11
Q2 2018 -$116M -$38.8M -$33.6M -655% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-11
Q1 2018 -$82.8M -$36.7M -$23.8M -185% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-11
Q4 2017 -$59M -$9.84M +$18.8M +65.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-11
Q3 2017 -$77.8M -$31.1M +$7.72M +19.9% Jul 1, 2017 Sep 30, 2017 10-K 2020-03-11
Q2 2017 -$85.5M -$5.14M +$35.4M +87.3% Apr 1, 2017 Jun 30, 2017 10-K 2020-03-11
Q1 2017 -$121M -$12.9M +$14.7M +53.3% Jan 1, 2017 Mar 31, 2017 10-K 2020-03-11
Q4 2016 -$136M -$28.6M -$424K -1.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$135M -$38.8M -$10.2M -35.8% Jul 1, 2016 Sep 30, 2016 10-K 2019-03-01
Q2 2016 -$125M -$40.5M -$15.5M -61.6% Apr 1, 2016 Jun 30, 2016 10-K 2019-03-01
Q1 2016 -$110M -$27.6M -$6.38M -30% Jan 1, 2016 Mar 31, 2016 10-K 2019-03-01
Q4 2015 -$103M -$28.2M -$42M -305% Oct 1, 2015 Dec 31, 2015 10-K 2019-03-01
Q3 2015 -$61.2M -$28.6M -$6.7M -30.6% Jul 1, 2015 Sep 30, 2015 10-K 2019-03-01
Q2 2015 -$54.5M -$25.1M +$1.41M +5.33% Apr 1, 2015 Jun 30, 2015 10-K 2018-03-07
Q1 2015 -$55.9M -$21.2M +$16.2M +43.3% Jan 1, 2015 Mar 31, 2015 10-K 2018-03-07
Q4 2014 -$72.1M $13.8M +$10M +267% Oct 1, 2014 Dec 31, 2014 10-K 2018-03-07
Q3 2014 -$82.1M -$21.9M -$10.6M -93.3% Jul 1, 2014 Sep 30, 2014 10-K 2018-03-07
Q2 2014 -$71.5M -$26.5M -$4.56M -20.8% Apr 1, 2014 Jun 30, 2014 10-K 2015-08-27
Q1 2014 -$67M -$37.4M -$36.1M -2754% Jan 1, 2014 Mar 31, 2014 10-K 2015-08-27
Q4 2013 -$30.8M $3.75M +$28.3M Oct 1, 2013 Dec 31, 2013 10-K 2015-08-27
Q3 2013 -$59.1M -$11.3M +$13.9M +55.1% Jul 1, 2013 Sep 30, 2013 10-K 2015-08-27
Q2 2013 -$73M -$21.9M +$372K +1.67% Apr 1, 2013 Jun 30, 2013 10-K 2014-08-28
Q1 2013 -$73.4M -$1.31M +$17.4M +93% Jan 1, 2013 Mar 31, 2013 10-K 2014-08-28
Q4 2012 -$90.8M -$24.5M -$11.7M -91.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-08-28
Q3 2012 -$79M -$25.2M -$5.78M -29.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-08-28
Q2 2012 -$73.3M -$22.3M -$6.12M -37.8% Apr 1, 2012 Jun 30, 2012 10-K 2013-08-29
Q1 2012 -$67.1M -$18.7M -$3.6M -23.8% Jan 1, 2012 Mar 31, 2012 10-K 2013-08-29
Q4 2011 -$63.5M -$12.8M +$2.74M +17.6% Oct 1, 2011 Dec 31, 2011 10-K 2013-08-29
Q3 2011 -$66.3M -$19.5M -$6.09M -45.5% Jul 1, 2011 Sep 30, 2011 10-K 2013-08-29
Q2 2011 -$60.2M -$16.2M Apr 1, 2011 Jun 30, 2011 10-K 2012-08-29
Q1 2011 -$15.1M Jan 1, 2011 Mar 31, 2011 10-K 2012-08-29
Q4 2010 -$15.5M Oct 1, 2010 Dec 31, 2010 10-K 2012-08-29
Q3 2010 -$13.4M Jul 1, 2010 Sep 30, 2010 10-K 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.